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Abstract
The immune cells named T lymphocytes circulate around the body fulfilling their role in immunosurveillance by monitoring
the tissues for injury or infection. To migrate from the blood into the tissues, they make use of the integrin LFA-1 which is
exclusively expressed by immune cells. These highly motile cells attach and migrate on substrates expressing the LFA-1
ligand ICAM-1. The molecular events signaling LFA-1 activation and adhesion are now reasonably well identified, but the
process of detaching LFA-1 adhesions is less understood. The cysteine protease calpain is involved in turnover of integrin-
mediated adhesions in less motile cell types. In this study we have explored the involvement of calpain in turnover of LFA-1-
mediated adhesions of T lymphocytes. Using live cell imaging and immunohistochemistry, we demonstrate that turnover of
adhesions depends on the Ca
2+-dependent enzyme, calpain 2. Inhibition of calpain activity by means of siRNA silencing or
pharmacological inhibition results in inefficient disassembly of LFA-1 adhesions causing T lymphocyte elongation and
shedding of LFA-1 clusters behind the migrating T lymphocytes. We show that calpain 2 is distributed throughout the T
lymphocyte, but is most active at the trailing edge as detected by expression of its fluorescent substrate CMAC,t-BOC-Leu-
Met. Extracellular Ca
2+ entry is essential for the activity of calpain 2 that is constantly maintained as the T lymphocytes
migrate. Use of T cells from a patient with mutation in ORAI1 revealed that the major calcium-release-activated-calcium
channel is not the ion channel delivering the Ca
2+. We propose a model whereby Ca
2+ influx, potentially through stretch
activated channels, is sufficient to activate calpain 2 at the trailing edge of a migrating T cell and this activity is essential for
the turnover of LFA-1 adhesions.
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Introduction
T lymphocytes circulate continuously in the blood with the
purpose of monitoring the tissues for injury or infection. They use
the integrin lymphocyte function–associated antigen-1 (LFA-1;
aLb2; CD11a/CD18) to migrate from the circulation across vessel
walls into lymph nodes and other tissues [1,2]. On the migrating
cell, clusters of high affinity LFA-1 are organised into a mid-cell
region of attachment termed the ‘‘focal zone’’ that corresponds to
the lamellar region in other cell types [3], while intermediate
affinity LFA-1 is expressed at the leading edge [4]. These two
conformations of LFA-1 co-operate to bring about efficient T
lymphocyte migration.
In migrating fibroblasts and endothelial cells, the cytosolic
cysteine protease calpain is responsible for the turnover of integrin-
mediated adhesions, promoting adhesion and spreading at the
leading edge and deadhesion at the rear of the cell [5,6]. Active
calpain is considered to function by cleaving proteins that are
constituents of adhesions [5,6]. In particular, a calpain-insensitive
mutant of talin prevented turnover of adhesions in fibroblasts [7].
There are two major calpain heterodimers, calpain 1(m/I) and
calpain 2(m/II) that share a subunit, calpain 4. Both forms have
been described to function in migration [5,6].
Calpain activity may be modulated, for example, by phospho-
inositide/lipid binding [8,9] or phosphorylation [10]. Phosphor-
ylation of calpain 2 following epidermal growth factor receptor
signalling occurs through the MAP kinase pathway involving ERK
and MEKK1 and requires no overt increase in cellular Ca
2+
[11,12]. However the calpains are considered to be Ca
2+ requiring
enzymes and, in cell-free assays, calpain activation is Ca
2+
-dependent, requiring 2-75 mM for calpain 1 and 200–1000 mM
Ca
2+ for calpain 2 [5,6]. How calpain activity is controlled in
intact cells where the steady state levels of Ca
2+ range between 50–
300 nM requires further resolution [13].
For lymphocytes, the process of store operated calcium entry
(SOCE) brings about Ca
2+ influx following engagement of
immunoreceptors such as the T cell or chemokine receptors
[14,15,16]. Signalling through PLCc leads to inositol-1,4,5-
triphosphate (IP3) binding to the IP3R-expressing Ca
2+ stores
and subsequent Ca
2+ release. The decrease of Ca
2+ in the stores is
sensed by stromal interaction molecule-1 (STIM1) which then
activates the main calcium-release-activated-calcium (CRAC)
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2+ influx
from the extracellular space. The transient receptor potential
(TRP) channel superfamily of .20 members comprises a second
type of ion channel. The TRP channels have enormous diversity
in terms of function and mechanisms of action, but their activity
differs from that of the CRAC channel, for instance, in lacking
Ca
2+ selectivity; whether some TRP channels are activated by
depletion of Ca
2+ stores is still a matter of controversy
[17,18,19,20]. Finally, the influx of Ca
2+ is modulated by
potassium efflux through the outwardly rectifying Kv1.3 and
KCa channels that generates negative membrane potential and
aids Ca
2+ influx through the CRAC channel.
Previously we demonstrated a role for calpain in the adhesion of
T lymphocytes to LFA-1 ligand intercellular adhesion molecule-1
(ICAM-1) [21]. It is known that calpain is involved in the migration
of slow movingcells suchas fibroblasts, butwhether calpain makes a
contribution to the migration of immune cells has been uncertain
with reports of a suppressive role in myeloid cells [22] and a recent
study in T lymphocytes indicating a null effect [23]. However other
studies in T lymphocytes show calpain to make a positive
contribution to adhesion and migration [24,25,26,27]. It is possible
that conflicting results are due to off-target effects of calpain
inhibitors. In this study we have used the approach of siRNA
knockdown, in addition to the most frequently used calpain
inhibitor, calpeptin. We show that turnover of LFA-1 adhesions is
controlled by calpain 2. Additionally we demonstrate that the
activation of this calpain in T lymphocytes predominates at the
trailing edge and is maintained by constitutive Ca
2+ signalling.
Results
A role for calpain in LFA-1-mediated migration of
T lymphocytes
To address whether calpain is involved in the migration of T
lymphocytes, the cell permeable calpain inhibitor, calpeptin, that
targets the active site of calpain [28] was added to T lymphoblasts
(T cells) migrating on ICAM-1. In untreated T cells, an F-actin
rich leading edge (red) was observed with LFA-1 expression (green)
displaying graded distribution towards the rear of the cell
(Fig. 1A). In the presence of calpeptin, this expression pattern
remained constant. However LFA-1 was also observed in punctate
adhesions behind each cell (see inset) (Fig. 1A).
Calpeptin was titrated to test whether blocking calpain activity
affected T cell migration. At a concentration of 50 mg/ml,
calpeptin reduced T cell speed by 76.665.2% (control-17.46
2.0 mm/min; 50 mg/ml calpeptin- 4.161.0 mm/min) (Fig. 1B).
Another general inhibitor of calpain, PD150606, that targets the
Ca
2+ binding site [28], had a similar effect (control- 14.460.8 mm/
min; 50 mg/ml PD150606- 3.060.3 mm/min). The random
pattern of migration of individual T cells was also prevented by
calpeptin (Fig. 1C).
Calpeptin-treated T cells that were fixed after 45 min of migration
and stained with high affinity LFA-1 mAb 24 displayed trails of the
integrin, highlighting the individual cell trajectories (Fig. 1D).
Although the cells undergo loss of LFA-1, it is apparent that
contractile forces are still able to move them forward at least for a
limited time period. Together the data show that active calpain has
an essential role in the migration of T cells at the level of LFA-1
adhesion turnover and that the adhesionsinclude high affinity LFA-1.
Calpain is required for turnover of LFA-1 adhesions at the
trailing edge of the T cell
We next investigated how calpain inhibition altered the
morphology of migrating T cells. Control T cells displayed the
classic ‘‘hand-mirror’’ shape with a spreading lamella at the
leading edge and a detached, upwardly projecting uropod at the
trailing edge (Fig. 2A). Following calpeptin treatment, T cells
continued to spread, but lost the distinctive uropod structure and
became elongated with the trailing edge attached to the
substratum.
To study the dynamics of this calpain-inhibited effect in more
detail, we performed live cell imaging with T cells that were
labelled with Alexa488-conjugated Fab’ fragments of a non-
function blocking LFA-1 mAb. The distribution of LFA-1 on the
migrating T cell was again skewed towards the rear in both
calpeptin-treated and untreated cells. Control T cells migrated
efficiently, detaching their trailing edges and maintaining uropods
(Fig. 2B; Movie S1). In contrast, as calpeptin-treated cells
migrated on ICAM-1, thin LFA-1-expressing extensions devel-
oped from the back of the cell. Eventually fresh adhesions and
forward movement caused sufficient membrane tension to rupture
the link with LFA-1 and release the trailing edge of the cell
(Fig. 2B; Movie S2).
By using the calpain substrate CMAC,t-BOC-Leu-Met (CMAC)
we could directly visualize calpain activity in migrating T cells. The
cleaved fluorescent product was highly concentrated at the rear of
the migrating T cell and at the interface with ICAM-1
(Fig. 2C). Treatment of T cells with calpeptin resulted in the loss
of CMAC fluorescence and therefore calpain activity. Calpain
inhibitionagaincausedthe appearanceofthinextensions attherear
of the cell. Thus active calpain is concentrated at the rear of the cell
and at the interface with ICAM-1.
Together these findings support the idea that calpain is involved
in the turnover of LFA-1 adhesions at the rear of the cell. When
calpain activity is blocked, the cell has difficulty in detaching so
that, as the front of the cell moves forward, there is trailing edge
elongation and loss of the uropod structure.
Calpain is activated by extracellular Ca
2+
In cell-free systems activation of calpain is Ca
2+-dependent, but
a role for Ca
2+, or indeed another divalent cation, in stimulating
calpain in intact immune cells such as T cells has not been
examined. Stimulating levels of cation could originate from several
sources: extracellular influx via cell membrane ion channels,
release from the intracellular Ca
2+ stores located in the
endoplasmic reticulum (ER) or from both sources [14,16,29].
We examined the effect of blocking the membrane ion channels
using pharmacological agents to see how the lack of ioninflux might
affect calpain activity. We tested SKF-96365, an imidazole used to
block receptor-mediated Ca
2+ entry [30], LaCl3, a cation channel
inhibitor used to block CRAC and TRP channels [14,31] and 2-
APB, an generalinhibitorof intracellularCa
2+ signaling [32]. When
calpain activity was visualized by microscopy, the three inhibitors
blocked formation of fluorescent CMAC and caused an elongated
morphology (Fig. 3A). These features were associated with a
reduction in migration, either when quantified by the tracking of
individual cells (Fig. 3B) or collectively as overall speed (Control,
13.261.3 mm/min; SKF-96365, 2.7060.64 mm/min (80.063.5%
decrease);LaCl3,0.960.13 mm/min(93.560.4% decrease);2-APB,
3.260.55 mm/min (76.562.562% decrease) (Fig. 3C).
When the effect of the inhibitors on the migratory phenotype
was viewed microscopically, they all caused cell lengthening
(Fig. 3D). The attached cells extended at their leading edges until
the increase in tension caused a rupture of the LFA-1 adhesions
(data not shown). The reduction in speed and elongated cell
morphology caused by the inhibitors was explained by the
restraining action of the more firmly attached trailing edge on
the active front of the cell that continued to move forward.
Calpain 2 Controls LFA-1 Deadhesion
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membrane ion channel was essential for maintenance of both
active calpain and migration of T cells. As calpain activity in vitro
has been demonstrated to be Ca
2+-dependent, it was important to
test whether a relevant ion channel was delivering Ca
2+ into the
cell. To locate cellular Ca
2+, T cells migrating on ICAM-1 were
loaded with the Ca
2+ binding Fluo-4 dye and examined by
fluorescent time-lapse confocal microscopy. The cells displayed
elevated Ca
2+ that was confined predominantly to the rear of the
cell and at the interface with ICAM-1 (Fig. 3E). A link between
the membrane ion channel and maintenance of the Ca
2+ level at
the rear of the cell was demonstrated by treating T cells with 2-
APB resulting in a substantial decrease in visible Ca
2+ (Fig. 3E).
The ORAI1-expressing CRAC channel is not involved in
calpain activation and T cell migration
The CRAC channel in human T cells contains the ORAI1
protein as a pore forming subunit and is essential for SOCE in T
cells and other immune cells [14,16,33]. To ask whether this Ca
2+
conducting channel was responsible for calpain activation and the
migration of T cells, we used a human T cell line derived from a
immunodeficient patient homozygous for a non-functional mutat-
ed ORAI1-R91W protein and compared its migratory potential
with a similarly maintained wild type control T cell line [34]. Both
control and mutant T cells migrated with similar morphology
(Fig. 4A) and speed (Fig. 4B) indicating that lack of a functioning
ORAI1-expressing CRAC channel did not adversely affect T cell
migration. Importantly when calpain activity was investigated,
active enzyme was present in a similar proportion of both control
and ORAI1 mutant T cells and at a similar level in the rear of the
cells (Fig. 4C, D). These findings indicated that the major CRAC
channel plays neither a role in migration nor in the general level of
calpain activation observed in T cells.
Calpain 2 is active at the trailing edge of the migrating T
cell
Since there are two major isoforms of calpain, 1 and 2,
expressed in migrating T cells, the next question was which
isoform might be active at the trailing edge. As might be expected
for cytosolic enzymes, both calpain 1 and calpain 2 were
distributed throughout the cell, from the leading edge, where
they overlapped with F-actin, to the trailing edge (Fig. 5A).
To identify which calpain isoform was active at the rear of the
cell, the individual calpains were specifically knocked down in
HSB2 cells (capn 1 siRNA by 75%; capn 2 siRNA1 by 86%, capn
2s i R N A 2b y8 5 % )( Fig. 5B). It was noted that reduction in one
calpain isoform did not affect the expression level of the other.
Knockdown of calpain 2, but not calpain 1 nor control siRNA-
treated cells, inhibited calpain activity at the trailing edge of the
migrating T cell showing active calpain 2 is concentrated in this
region (Fig. 5C,D). Finally to demonstrate a role for the calpain
2 isoform in T cell migration, we showed that knockdown of
calpain 2, but not calpain1, inhibited T cell migration at both the
level of single cell tracking (Fig. 5E)a n dg e n e r a lc e l ls p e e d
(Fig. 5F).
In summary, although calpeptin is considered a specific
inhibitor of the calpains, siRNA knockdown of calpain is more
selective and allowed discrimination between the two calpains
isoforms. We have therefore been able to show that, in spite of the
general distribution of both calpain 1 and calpain 2 within the T
cell, it is calpain 2 that is active at the rear of the T migrating cell.
Discussion
In this study we show that calpain 2 has an essential role in
releasing the LFA-1 adhesions of migrating T lymphocytes and
that this calpain is maintained in an active state by Ca
2+ ion
channel activity. Inhibition of calpain 2 by calpain inhibitors and
by siRNA silencing, causes reduced speed of migration by
interfering with LFA-1 detachment at the trailing edge of the
migrating T cell. The T cell can however shed integrin in the
absence of efficient adhesion turnover, potentially through tension
generated by trailing edge contraction. Over time, this results in
trails of released LFA-1 adhesions that highlight the cell’s
trajectory.
There are conflicting findings over the role of calpains in
integrin-mediated adhesion events in T cells. Our previous study
and others indicate that calpain has a positive role in terms of
promoting LFA-1- and b1- mediated integrin adhesion
[21,24,25,26,27]. However in a recent report, no LFA-1 related
adhesion defects were observed in T cells from mice where the
calpain 4 subunit shared by calpain 1 and calpain 2 was
conditionally deleted [23]. Previous studies, and also this present
one, have made use of calpain inhibitors raising the possibility of
non-specific effects. However we have also used siRNA knock-
down to specifically reduce levels of both calpain 1 and 2 and
observe specific effects of active calpain 2 on the migratory
behavior of T cells. Other possibilities that might be considerd are
that differences exist in calpain usage between mouse and human
T cells, that the lack of calpain 4 was compensated for in
generating active calpain 1 or 2 and finally there might be
functional interplay between calpain 1 and 2 as has been reported
previously [35] with still-to-be-explored functional consequences.
We show here that the clusters of T cell adhesions containing
high affinity LFA-1 require a calpain-dependent step to deadhere.
Consistent with these results are single particle tracking studies
showing that calpain is responsible for releasing the immobile
active form of LFA-1 on the membrane [26]. There is also a
requirement for a calpain-mediated step when adhesion occurs
under conditions of shear flow mimicking the circulation [36].
This is most relevant when ICAM-1 levels are low and turnover of
LFA-1 is required to release old adhesions and form new ones.
Another issue is that T cells express both calpain 1 and calpain 2
and immunostaining indicates that both isoforms are distributed
throughout the T cell. A question is why it is calpain 2, rather than
calpain 1, that mediates the release of the LFA-1 adhesions. A
major controlling factor may be the exact location of the calpains
Figure 1. Calpain regulation of T cell migration. (A) T lymphoblasts were allowed to migrate for 15 min on ICAM-1 in the presence or absence
of calpain inhibitor, calpeptin, before fixation. Total LFA-1 was detected using anti-LFA-1 mAb 38 and F-actin with fluorescently-labelled phalloidin.
Panels are composite images of Z sections through the cells starting from the interface with ICAM-1. LFA-1 mAb (green), F-actin (red). Inset: higher
magnification view of the LFA-1 trails shows distinct clusters of integrin. Scale bar=10 mm. Images are representative of n=4 experiments; (B) The
calpain inhibitor, calpeptin, reduces the speed of migration on the LFA-1 ligand ICAM-1. For untreated and calpeptin-treated T cells, the speed was
calculated for 20 cells over a 15 min period, n=4; (C) Calpain regulation of T cell migration. Individual T cells display random migration when
observed for 15 min with reduced migration following calpeptin treatment (50 mg/ml) (n=20 T cells/experiment, n=3 experiments); (D) Detail of
LFA-1 clusters detected with mAb 24 in trails of calpain-inhibited migrating T cells after 45 min. The panel is a composite image of Z sections through
the T cells. LFA-1 mAb 24 (green), F-actin (red), Scale bar=10 mm. Images are representative of n=4 experiments.
doi:10.1371/journal.pone.0015090.g001
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PLoS ONE | www.plosone.org 4 November 2010 | Volume 5 | Issue 11 | e15090Figure 2. The effect of calpain inhibition and location of active calpain in T cells. (A) Effect of calpain inhibition on T cell morphology. The
proportion of untreated and calpeptin-treated T cells with a detached uropod (n=50 per data set). Representative images of untreated and
calpeptin-treated T cells are shown with the uropod and trailing edge respectively indicated by a white asterisk. *P,0.05; (B) Effect of calpain block
on distribution of LFA-1 and morphology of migrating T cells over time (seconds). T cells were labelled with Alexa488 conjugated-Fab’ fragments of a
non-function affecting anti-LFA-1 mAb YTH81.5 (green), then allowed to migrate on ICAM-1-coated substrate 6 calpeptin. Images are representative
of n=4 experiments; (C) Distribution of active calpain in T cells loaded with calpain substrate CMAC,t-BOC-Leu-Met and adhered to ICAM-1 6
calpeptin. Z section images were taken through migrating cells at 2 mm intervals from the level of T cell/ICAM-1 interface. Pseudo-color glow scale
(red, highest to blue, lowest activity). Scale bar=10 mm, images are representative of n=4 experiments.
doi:10.1371/journal.pone.0015090.g002
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considered to be cytosolic enzymes, there is evidence that calpain 2
is associated with cellular membranes through phosphoinositide
binding, and this could give greater access to membrane bound
ion channels [9,37].
Of relevance is the level of Ca
2+ required to activate calpain 2.
Steady state intracellular Ca
2+ levels range between 50–300 nM,
whereas in cell free assays calpain 2 is activated by 200-1000 mM
levels of Ca
2+ [13]. We show here that intracellular Ca
2+ is highest
at the T cell membrane interface with ICAM-1. In terms of
activating intracellular calpain-2, Ca
2+ could be delivered locally
at the membrane in a sufficiently high concentration. Ca
2+ levels
up to 100 mM have been recorded within 20 nm of Ca
2+ channels
and this may be sufficient to maintain calpain 2 activity [38,39]. As
a consequence, calpain-2 may well be colocalized with a Ca
2+
channel to ensure the high, localized Ca
2+ concentrations that are
required for its activity.
Our findings demonstrate an essential requirement for a Ca
2+
-conducting ion channel in regulating both calpain 2 activity and
LFA-1-mediated migration. The channel appears to be providing
a constitutive or ‘‘tonic’’ signal as the T cells require no added
stimulus in order to migrate. A key question is how this activity is
initiated and maintained. Cell migration is known to be affected by
stretch-activated calcium channels [40,41]. The activity of such a
channel, most highly expressed at the rear of the polarized cell,
would provide an explanation for maintenance of the Ca
2+ levels
and calpain 2 activity.
The major ion channel that delivers Ca
2+ into the cell is the
ORAI1-CRAC channel that is activated by depletion of Ca
2+
from the ER stores. It is of interest that it is not required for
calpain activity or migration in T cells. Another candidate Ca
2+
channel in T cells is TRPM7, a non-selective cation channel that is
permeable to Ca
2+ and also to Mg
2+ and is an atypical TRP
channel in expressing a C terminal a-kinase [42,43,44]. It is
associated with calpain in fibroblast focal adhesions [31,45] and
there is some evidence that it can act as a mechanosensitive
channel that is activated by shear stress of laminar flow [46].
Taqman assay revealed low levels of TRPM7 in T lymphoblasts
and HSB2 cells (data not shown). However, the role of TRPM7 for
migration and calpain activity in human T cells could not be tested
in the present study because, despite much effort, it proved
impossible to reduce TRPM7 levels using the siRNA approach
(data not shown). TRPM7 remains a good candidate as it is
associated with Ca
2+ influx and migration in other cell types
[47,48].
The distinction in terms of function between the ORAI1-CRAC
channel and the calpain 2-activating ion channel described in this
study may have to do with compartmentalisation of Ca
2+ influx.
Our evidence suggests that calpain 2 is activated close to the T cell
membrane and this is consistent with the finding that LFA-1-
dependent Ca
2+ entry can occur without the release of
intracellular Ca
2+ [49]. On the other hand, ORAI1-CRAC
channels are activated upon Ca
2+ store depletion giving rise to a
more global elevation of Ca
2+ within the cell and this distribution
may have other consequences. For example Ca
2+ influx through
the CRAC channel plays a major role in controlling transcription
of immune mediators such as cytokines in response to immunor-
eceptor engagement and resulting in activation of the calcineurin/
NFAT pathway [14,16].
In summary, we show in this study that calpain-2 regulates the
release of LFA-1 adhesions in migrating T lymphocytes, and is
maintained in a constitutively active state dependent on influx of
Ca
2+. The lack of involvement of the major ORAI1-expressing
CRAC channel has been unexpected and points to a clear
distinction in the roles of Ca
2+ delivering ion channels in T
lymphocyte function.
Materials and Methods
Inhibitors, antibodies and other reagents
LFA-1 mAbs 38 and YTH 81.5 were produced at Cancer
Research UK and Fab’ fragments of mAb YTH81.5 directly
conjugated to Alexa-488 fluorochrome as previously described [3].
Calpain 2 mAb 3A11D12 was kindly provided by Dr. Mitsuchi
Inomata [50]. The following mAbs were purchased: calpain 1,
Calbiochem; calpain 2, Research Diagnostics; a-tubulin, Sigma.
The calpain inhibitors were purchased from Merck Biosciences:
calpeptin (50 mg/ml unless stated) and PD150606 (50 mg/ml). The
following reagents were purchased as indicated: 2-APB, Merck
Bioscience; lanthanum chloride (LaCl3), Sigma; SKF-96365,
Sigma; pre-designed siRNAs for calpain 1 (ID 146578), calpain
2 (ID 112796 and 145947), and siRNA control #2 were all from
Ambion; CAPN1 13 and 10, CAPN2 1 and 6 and negative control
were from Qiagen.
Cell isolation, culture and electroporation
Peripheral blood mononuclear cells were prepared from single
donor leukocyte buffy coats (National Blood Service) and T cells
expanded as previously described and used between days 10 and
14 [21]. The human CD3
- leukemic T cell line, HSB2 was
maintained in RPMI 1640/10% FCS [51]. Human polyclonal,
non-transformed T cell lines from an ORAI1-mutated patient and
wild type control were generated as previously described [34] and
maintained in RPMI/10% FCS in the presence of IL-2.
For siRNA knockdown experiments, HSB2 T cells line were
washed twice in OptiMEM+GlutaMAX (Invitrogen) and electro-
poration was performed on 2610
7 cells with 200–400 nM siRNAs
using a Gene Pulser with Capacitance Extender (Bio-Rad) set at
960 mFD and 260 mV as previously described [3]. The siRNA-
electroporated cells were maintained in RPMI 1640/10% FCS for
24 h prior to use. The efficiency of knockdown was evaluated by
Western blot analysis for calpain with quantification using NIH
image 1.63 software.
Microscopy
i. Video microscopy. 35 mm glass bottomed petri dishes
(MatTek Corp., Ashland Mass. USA) or or m-slides VI (Ibidi,
Thistle Scientific Ltd, Glasgow, UK) were coated overnight at 4uC
with 3 mg/ml ICAM-Fc then blocked for non-specific binding with
2.5% BSA/PBS for 1 h at RT as previously [3]. T cells were
Figure 3. Effect of Ca
2+ channel inhibitors on calpain activity and T cell migration. Effect of ion channel inhibitors 2-APB (50 mM), SKF-
96365 (100 mM), LaCl3 (2 mM) on the following (A–D): (A) Calpain activity as detected by expression of calpain substrate CMAC,t-BOC-Leu-Met.
Pseudo-color glow scale (red, highest to blue, lowest activity). Outline of DIC image shown as a white tracing. Scale bar=10 mm. Images are
representative of n=4 experiments; (B) Individual T cells show random migration following observation for 20 min (n=15 cells, n=3 experiments);
(C) Overall speed of T cell migration (n=15 cells). *** P,0.001; (D) Cell length of migrating cells, n=25 cells. *** P,0.001; (E)C a
2+ levels observed in T
cells polarized on ICAM-1 before and after treatment with 2-APB. Panels show Z sections from the level of the ICAM-1/T cell interface up through the
cell at 2 mm intervals. Pseudo-colour glow scale (red, highest to blue, lowest activity). Scale bar=10 mm; images are representative of n=3
experiments.
doi:10.1371/journal.pone.0015090.g003
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5 cells added to dishes containing
HBSS/20 mM HEPES. Cells migrated for 15 min at 37uC prior
to initiation of the experiment. Images were captured with an
Olympus MTV3 Inverted microscope and a 206lens or a Zeiss
Axiovert 135TV Inverted microscope and a 636 lens plus
AQM
2001 Kinetic Acquisition Manager software (Kinetic
Imaging Ltd., Bromborough, UK). Cells were tracked using
Motion Analysis software (Kinetic Imaging Ltd.) and data
analysed using a Mathematica notebook (Wolfram Research
Europe Ltd, Long Hanborough, UK) developed by Daniel Zicha
(Cancer Research UK, London).
ii. Live cell imaging of LFA-1 distribution. T cells
(2610
5/ml) were labelled with Alexa488-conjugated YTH81.5
Fab’ fragments (10 mg/ml) for 15 min at 37uC, washed and added
to ICAM-1Fc-coated MatTek dishes as described above. T cells
were allowed to migrate for 20 min 650 mg/ml calpeptin, then
images were taken at 10 second intervals using a Zeiss Axiovert
microscope and a LSM-510 laser scanning system.
iii. Live cell imaging of calpain activity. T cells or HSB2
T cells at 5610
6 cells/ml were labelled with the calpain substrate
CMAC,t-BOC-Leu-Met (20 mM; Invitrogen) for 10 min at 37uC
[52], washed and added to ICAM-1Fc-coated MatTek or m-slide
VI dishes as described above. Images were taken using a Zeiss
Axiovert microscope with Blue Diode and a LSM-510 laser
scanning system within 20 min.
iv. Confocal microscopy. T lymphoblasts 6 calpeptin,
exposed to ICAM-1Fc coated coverslips for 40 min at 37uC,
were fixed with 3% formaldehyde in HBSS for 20 min at RT.
Coverslips were incubated with 10 mg/ml of LFA-1 mAb in HBSS
containing 0.25% BSA for 1 h at RT. Cells were permeabilised
with 0.1% Triton-X-100, for 4 min at RT then incubated with
2.5 units/ml Alexa 546-phalloidin and Alexa 488-goat anti-mouse
IgG (1:200; Invitrogen) for 1 h at RT. Finally, coverslips were
mounted in Mowiol antifadent (Merck Biosciences) and images
collected on a Zeiss Axioplan microscope with a LSM510 laser
scanning system.
Figure 4. Investigation of ORAI1 mutant T cell calpain activity and migration. (A) Morphology of control and ORAI1 mutant T cell lines
migrating on ICAM-1. White arrow indicates the leading edge of the T cell; n=3 complete sets of experiments for each cell line; (B) Overall speed of
migration (n=12 T cells); (C) Calpain activity of individual control and ORAI1 mutant T cell lines as detected by expression of calpain substrate
CMAC,t-BOC-Leu-Met. Pseudo-color glow scale (red, highest to blue, lowest activity). Outline of DIC image shown as a white tracing. Scale
bar=10 mm; (D) Proportion of total T cells expressing CMAC activity (n=15 cells).
doi:10.1371/journal.pone.0015090.g004
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2+. T cells were labelled
with Fluo-4 (1 mM; Invitrogen) plus 10% w/v Pluronic 127
(Invitrogen) for 60 min at 37uC, washed and added to ICAM-1Fc-
coated dishes (MatTek) as described above. Cells were visualized
by phase contrast and the Ca
2+ flux by excitation at 480 nm and
emission at 516 nm. Images were taken at 30 sec intervals using a
Zeiss Axioplan microscope with a LSM510 laser scanning system.
SDS-PAGE and Western blotting of calpain siRNA treated
HSB2 cell extracts
HSB2 T cells were lysed at 5610
7/ml for 20 min on ice in
50 mM Tris pH7.4 containing 150 mM NaCl, 1% Triton X-100,
20 mg/ml PMSF and a complete protease inhibitor cocktail tablet
(Roche). The lysate was microfuged for 15 min to remove
insoluble material. Proteins were separated under reducing
conditions by SDS-PAGE. After transfer to nitrocellulose
membrane and incubation with antibodies, bound antibody was
detected with HRP-conjugated sheep anti-mouse Ig (GE Health-
care, UK) and ECL Western blotting detection reagents (GE
Healthcare).
Statistical Analysis
The significance of the migration assays was determined using 2
Way Anova (Mathematica notebook (Wolfram Research) further
developed by Daniel Zicha (Cancer Research UK)). The
significance of other analyses (Fig. 2A, 3D) was tested using the
unpaired Student t test (GraphPad Prism software version 5 for
Macintosh computers). Fisher’s Exact Test was used to the analyse
the pooled data from 2-5 experiments represented in Fig. 5D. The
following significant differences are as indicated: *, P,0.05;
**, P,0.01; ***, P,0.001.
Supporting Information
Movie S1 The distribution of LFA-1 on human T lymphoblasts
migrating on ICAM-1. LFA-1 is labelled with Alexa488-
conjugated Fab’ of non-function-blocking mAb YTH81.5.
(AVI)
Movie S2 The distribution of LFA-1 on human T lymphoblasts
migrating on ICAM-1 following treatment with calpeptin at
50 mg/ml. LFA-1 is labelled with Alexa 488-conjugated Fab’ of
non-function–blocking mAb YTH81.5.
(AVI)
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